Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS1008A Buprenorphine/Naloxone in Opiate Dependence
NCT00015028Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Nov 1996
- Primary completion
- Dec 1996
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid use disorder (OUD) comparing Buprenorphine/naloxone with Placebo (2 arms). Primary endpoints: Craving, Drug use and 3 more. Started Nov 1996; status: completed.
02
Drugs
buprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00015028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015028.